ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $816,000 | -63.3% | 50,000 | -81.2% | 0.48% | -45.4% |
| Q2 2017 | $2,223,000 | +11.5% | 265,589 | +19.1% | 0.88% | +49.7% |
| Q1 2017 | $1,994,000 | +44.2% | 223,000 | +41.7% | 0.59% | +16.4% |
| Q4 2016 | $1,383,000 | +581.3% | 157,360 | +424.5% | 0.51% | +717.7% |
| Q3 2016 | $203,000 | – | 30,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |